Long Noncoding RNAs: Clarity or Confusion?
Because They Are Such Elusive Prey, lncRNAs Have Yet to Emerge as Therapeutic Targets
Markets Expand for Single-Use Bioreactors
Biobags Offer Advantages Over Fixed-Tank Systems
The Challenges of Harmonizing Biomarker Data
Why Trial Success Depends on It
Top 10 Wall Street Losers of 2016
These Companies Lost the Most in a Down Year for Biopharma Stocks
- Hamamatsu Photonics
- 360 Foothill Rd.
- Bridgewater NJ, 08807
- UNITED STATES
Hamamatsu has been working with the Photon for more than 50 years. We have established ourselves as the top company of photoelectron conversion technologies in the world. However, we have yet to fully grasp the nature of the Photon and its potential. The more you study, the more you realize how little you know about the Photon and its applications. That is why we continue to move ahead vigorously with basic research and apply what we learn to photonics.